H&E Equipment Services Reports Quarterly Cash Dividend
BATON ROUGE, La., Aug. 13, 2024 (GLOBE NEWSWIRE) -- H&E Equipment Services, Inc. (NASDAQ: HEES) announced that its Board of...
BATON ROUGE, La., Aug. 13, 2024 (GLOBE NEWSWIRE) -- H&E Equipment Services, Inc. (NASDAQ: HEES) announced that its Board of...
Received NMPA approval of avatrombopag maleate tablets for the treatment of CLD-associated thrombocytopenia, expanding rare disease product linesReceived IND approval...
Contacts Investors (English): ir@faradayfuture.com Investors (Chinese): cn-ir@faradayfuture.com Media: john.schilling@ff.com Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or...
~ Achieved Second Quarter 2024 Total Net Revenues of $7.3 Million ~~ Appointed Jeffrey S. Hackman as Chief Executive Officer...
HESPERIA, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”),...
EMERYVILLE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic...
Key scientific achievements drive the expansion of the pipeline of molecular glue degraders Performance-based and programme-based payments of in total...
TORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF) (the “Company” or “Goliath”)...
REHOVOT, Israel, Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company...
COPENHAGEN, Denmark, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio...
GUANGZHOU, China, Aug. 12, 2024 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading...
LIER, Belgium and ATLANTA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting...
Contacts Company Contact: Diodes Incorporated Gurmeet Dhaliwal Director, Investor Relations and Corporate Marketing P: 408-232-9003 E: gurmeet_dhaliwal@diodes.com Investor Relations Contact:...
RENO, Nev., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an...
RENO, Nev., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an...
Contacts Tom Filandro ICR, Inc. CitiTrendsIR@icrinc.com Citi Trends, Inc. (NASDAQ: CTRN) today announced plans to release its earnings for the...
- Completed enrollment in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with early-stage dementia with Lewy bodies...
-- Highly-experienced hematologist and oncologist with proven track record successfully driving global clinical development of CAR-T cell therapies --BERKELEY, Calif.,...
Contacts Investors David Snyder david@coyatherapeutics.com CORE IR Bret Shapiro brets@coreir.com 561-479-8566 Media Kati Waldenburg media@coyatherapeutics.com 212-655-0924 Coya Therapeutics, Inc. (Nasdaq:...
TACOMA, Wash., Aug. 12, 2024 /PRNewswire/ -- Columbia Banking System, Inc. ("Columbia"Nasdaq: COLB), parent company of Umpqua Bank, today announced...
Company continues to make significant progress towards disrupting the existing cochlear implant industry with its investigational, breakthrough fully implanted Acclaim®...
BOSTON and LONDON, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims...
– Phase 3 ACTION Study On-Track; First Interim Overall Survival Data Expected Third Quarter 2025 – – ONC206...
BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...
FLORHAM PARK, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...
WALTHAM, Mass., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology...
ANN ARBOR, Mich., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"),...
Current hashrate of ~8.7 EH/s on target for ~13.5 EH/s by end of 2024 and ~35.0 EH/s by end of...
Current hashrate of ~8.7 EH/s on target for ~13.5 EH/s by end of 2024 and ~35.0 EH/s by end of...
Establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources Sale follows robust...
Latest Design IP Report from IPNest ranks Ceva #1 in Wireless Interface IP Revenue for 2023 with 67% market share,...
Contacts Investor Inquiries Steven O'Brien Vice President, Investor Relations (847) 968-0238 investorrelations@cdw.com Media Inquiries Sara Granack Vice President, Corporate Communications...
TALLAHASSEE, Fla., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Capital City Bank is proud to announce Lynne Jensen has been promoted...
STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX) : April to June 2024 (compared to...
WUHAN, China, Aug. 13, 2024 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering...
CICERO, Ill., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized...
DALLAS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced that its press...
Contacts Investors: Courtney O’Leary, 978-621-7347 coleary@bluebirdbio.com Media: Jess Rowlands, 857-299-6103 jess.rowlands@bluebirdbio.com bluebird bio, Inc. (Nasdaq: BLUE) announced today that it...
Quarter highlights include new product launch, progress on next-gen plate manufacturing, and data center market development VANCOUVER, BC, Aug. 12,...
FORNEBU, Norway, Aug. 13, 2024 /PRNewswire/ -- Reference is made to Akastor ASA's (OSE: AKAST) press release 3 June 2024 concerning its...